Bladder cancer is a global health issue with sex differences in incidence and prognosis.
Bladder cancer has distinct molecular subtypes with multiple pathogenic pathways …

Purpose To learn about the history and development of en bloc resection of bladder tumour
(ERBT), and to discuss its future directions in managing bladder cancer. Methods In this …

Background En bloc transurethral resection of the bladder (eTURB) might improve the
surgical management of non–muscle-invasive bladder cancer (NMIBC) in comparison to …

Background We aimed to assess the clinical, oncological, and pathological impact of en bloc
resection of bladder tumors (ERBT) compared with conventional transurethral resection of …

Background High-level evidence supporting the role of repeat transurethral resection
(reTUR) in non–muscle-invasive bladder cancer (NMIBC) is lacking. A randomized …

1.1 Aim and scope This overview represents the updated European Association of Urology
(EAU) Guidelines for Non-muscleinvasive Bladder Cancer (NMIBC), TaT1 and carcinoma in …

Background The number of studies suggesting that en bloc resection of bladder tumor
(ERBT) is superior to transurethral resection of bladder tumor (TURBT) for non-muscle …

Bladder cancer (BC) possesses distinct molecular profiles that influence progression
depending on its biological nature and delivered treatment intensity. Muscle-invasive BC …

Bladder cancer is a heterogeneous disease. Treatment decisions are mostly decided based
on disease stage (non-muscle invasive or muscle invasive). Patients with muscle-invasive …

Abstract Background En‐Bloc transurethral resection of bladder tumor (ERBT) was clinically
used to resect non‐muscle‐invasive bladder cancer (NMIBC). However, discrepancies …